CorMedix Inc. (NASDAQ:CRMD – Get Rating) saw a large growth in short interest during the month of April. As of April 30th, there was short interest totalling 2,220,000 shares, a growth of 8.3% from the April 15th total of 2,050,000 shares. Based on an average trading volume of 257,500 shares, the short-interest ratio is currently […]
CorMedix Inc. (NASDAQ:CRMD – Get Rating) was the target of a significant growth in short interest in April. As of April 30th, there was short interest totalling 2,220,000 shares, a growth of 8.3% from the April 15th total of 2,050,000 shares. Based on an average trading volume of 257,500 shares, the short-interest ratio is presently […]
Needham & Company LLC reissued their buy rating on shares of CorMedix (NASDAQ:CRMD – Get Rating) in a research note released on Friday morning, Benzinga reports. The firm currently has a $13.00 target price on the stock. Separately, JMP Securities reiterated a market outperform rating and set a $16.00 price target on shares of CorMedix […]
Needham & Company LLC restated their buy rating on shares of CorMedix (NASDAQ:CRMD – Get Rating) in a report released on Friday morning, Benzinga reports. Needham & Company LLC currently has a $13.00 price objective on the stock. Separately, JMP Securities reaffirmed a market outperform rating and set a $16.00 price target on shares of […]
Needham & Company LLC reiterated their buy rating on shares of CorMedix (NASDAQ:CRMD – Get Rating) in a report released on Friday, Benzinga reports. The firm currently has a $13.00 price target on the stock. Separately, JMP Securities reiterated a market outperform rating and issued a $16.00 price objective on shares of CorMedix in a […]